Form 4: West Pharmaceutical Services Director Acquires Shares

Director Robert F. Friel acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Summary

• Robert F. Friel, a director of West Pharmaceutical Services Inc., reported a transaction on April 23, 2024.
• Friel acquired 564 shares of common stock at $0 per share, resulting in a directly held total of 3,610.98 shares.
• The acquired shares are restricted stock units that will vest on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't convey any particular positive or negative sentiment about the company's performance or prospects.

Future Outlook

The restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for directors and officers of publicly traded companies. It provides transparency to investors regarding the actions of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the director's investment in the company.

Key Dates